Literature DB >> 21543931

Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens.

Hui Guan1, Assaad Semaan, Sudeshna Bandyopadhyay, Haitham Arabi, Jining Feng, Lamia Fathallah, Vaishali Pansare, Aamer Qazi, Fadi Abdul-Karim, Robert T Morris, Adnan R Munkarah, Rouba Ali-Fehmi.   

Abstract

BACKGROUND: The current International Federation of Gynecology and Obstetrics (FIGO) grade in endometrial carcinomas requires the evaluation of histologic features with proven prognostic value but with questionable reproducibility. This study tests the prognostic power and reproducibility of a new binary grading system. STUDY
DESIGN: Specimens from 254 hysterectomies were graded according to the new 3- and 2-tiered FIGO grading systems described by Alkushi et al. The selected morphologic parameters for the new grading system included the presence of predominant solid or papillary architecture pattern, severe nuclear atypia, tumor necrosis, and vascular invasion. The Cox proportional hazards and κ statistics were used for comparisons.
RESULTS: On multivariate analysis, and looking at all tumor cell types, the 4 tested grading systems were independent predictors of survival, with the 3-tiered FIGO grading system being the most predictive (P = 0.005). In the subset of endometrioid tumors, the 3- and 2-tiered FIGO grading systems and the new grading system retained their statistical significance as predictors of survival (P = 0.004, P = 0.03, and P = 0.007, respectively), whereas the grading system of Alkushi et al did not (P = 0.1). In nonendometrioid tumors, the new grading system proved to be the best predictor of survival, reaching near statistical significance (P = 0.06). The new grading system had acceptable intraobserver and interobserver reproducibility assessment (κ = 0.87 and κ = 0.45, respectively).
CONCLUSION: The 3-tiered FIGO grading system retained its superior prognostic power. However, available binary grading systems remain an attractive option by being highly reproducible and by eliminating the clinical ambiguity of intermediate grades of disease.

Entities:  

Mesh:

Year:  2011        PMID: 21543931     DOI: 10.1097/IGC.0b013e31821454f1

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  10 in total

1.  Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma.

Authors:  Mathilde Mairé; Aurélien Bourdon; Isabelle Soubeyran; Carlo Lucchesi; Frédéric Guyon; Guillaume Babin; Anne Floquet; Adeline Petit; Jessica Baud; Valérie Velasco; Denis Querleu; Sabrina Croce
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

2.  Prognostic impact of histological review of high-grade endometrial carcinomas in a large Danish cohort.

Authors:  Marie Boennelycke; Elke E M Peters; Alicia Léon-Castillo; Vincent T H B M Smit; Tjalling Bosse; Ib Jarle Christensen; Gitte Ørtoft; Claus Høgdall; Estrid Høgdall
Journal:  Virchows Arch       Date:  2021-06-11       Impact factor: 4.064

3.  Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.

Authors:  Aline Talhouk; Lien N Hoang; Melissa K McConechy; Quentin Nakonechny; Joyce Leo; Angela Cheng; Samuel Leung; Winnie Yang; Amy Lum; Martin Köbel; Cheng-Han Lee; Robert A Soslow; David G Huntsman; C Blake Gilks; Jessica N McAlpine
Journal:  Gynecol Oncol       Date:  2016-07-14       Impact factor: 5.482

4.  A clinically applicable molecular-based classification for endometrial cancers.

Authors:  A Talhouk; M K McConechy; S Leung; H H Li-Chang; J S Kwon; N Melnyk; W Yang; J Senz; N Boyd; A N Karnezis; D G Huntsman; C B Gilks; J N McAlpine
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

Review 5.  Fertility-preservation in endometrial cancer: is it safe? Review of the literature.

Authors:  Márcia Mendonça Carneiro; Rívia Mara Lamaita; Márcia Cristina França Ferreira; Agnaldo Lopes Silva-Filho
Journal:  JBRA Assist Reprod       Date:  2016-12-01

6.  Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.

Authors:  Elke E M Peters; Carla Bartosch; W Glenn McCluggage; Catherine Genestie; Sigurd F Lax; Remi Nout; Jan Oosting; Naveena Singh; Huub C S H Smit; Vincent T H B M Smit; Koen K Van de Vijver; Tjalling Bosse
Journal:  Histopathology       Date:  2019-06-10       Impact factor: 5.087

7.  Relationships of nuclear, architectural and International Federation of Gynecology and Obstetrics grading systems in endometrial cancer.

Authors:  Tayfun Toptaş; Elif Peştereli; Selen Bozkurt; Gülgün Erdoğan; Tayup Şimşek
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-10-26

8.  Myoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma.

Authors:  Min Hye Kim; Dae Hyun Song; Gyung Hyuck Ko; Jeong Hee Lee; Dong Chul Kim; Jung Wook Yang; Hyang Im Lee; Hyo Jung An; Jong Sil Lee
Journal:  J Pathol Transl Med       Date:  2018-03-14

9.  A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?

Authors:  Simone Marnitz; Till Walter; Birgid Schömig-Markiefka; Tobias Engler; Stefan Kommoss; Sara Yvonne Brucker
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

10.  Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis.

Authors:  Ya He; Tian Wang; Na Li; Binkai Yang; Yuanjing Hu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.